First biopsy | Second biopsy | |
---|---|---|
Clinical presentation | CGN | RPGN |
U-P 3.2 g/g·Cr | U-P 12.3 g/g·Cr | |
U-RBC 50–99/HPF | U-RBC > 100/HPF | |
sCr 0.74 mg/dL | sCr 5.5 mg/dL | |
Anti-GBM antibody | Not tested | 116 IU/ml |
Light microscopy | Mesangial proliferative GN | Crescentic GN |
Global sclerosis (1/19) | Global sclerosis (6/31) | |
Fibrocellular crescent (1/19) | Cellular~fibrocellular crecent (18/31) | |
Immunofluorescence | IgA: mes ++ | IgA: mes + |
C3: mes ++ | C3: mes + | |
IgG: mes +, | peripheral linear + | |
peripheral linear ± | IgG: peripheral linear ++ | |
(focal segmental) | (diffuse global) |